Related Experiment Video
Updated: Dec 24, 2025
Pentylenetetrazole-Induced Kindling Mouse Model
Published on: June 12, 2018
1,2,4-Triazole-based anticonvulsant agents with additional ROS scavenging activity are effective in a model of
Barbara Kaproń1, Robert Czarnomysy2, Mariusz Wysokiński3
1Department of Clinical Genetics, I Faculty of Medicine with Dentistry Division, Medical University of Lublin, Lublin, Poland.
Abstract:
There are numerous studies supporting the contribution of oxidative stress to the pathogenesis of epilepsy. Prolonged oxidative stress is associated with the overexpression of ATP-binding cassette transporters, which results in antiepileptic drugs resistance. During our studies, three 1,2,4-triazole-3-thione derivatives were evaluated for the antioxidant activity and anticonvulsant effect in the 6 Hz model of pharmacoresistant epilepsy. The investigated compounds exhibited 2-3 times more potent anticonvulsant activity than valproic acid in 6 Hz test in mice, which is well-established preclinical model of pharmacoresistant epilepsy. The antioxidant/ROS scavenging activity was confirmed in both single-electron transfer-based methods (DPPH and CUPRAC) and during flow cytometric analysis of total ROS activity in U-87 MG cells. Based on the enzymatic studies on human carbonic anhydrases (CAs), acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), one can assume that the herein investigated drug candidates will not impair the cognitive processes mediated by CAs and will have minimal off-target cholinergic effects.
Insights
New 1,2,4-triazole-3-thione derivatives show potent antioxidant and anticonvulsant effects against drug-resistant epilepsy. These compounds outperform valproic acid in preclinical models, offering a promising avenue for epilepsy treatment.
Area of Science:
- Neuroscience
- Pharmacology
- Medicinal Chemistry
Background:
- Oxidative stress contributes to epilepsy pathogenesis and antiepileptic drug resistance.
- ATP-binding cassette transporters are overexpressed during prolonged oxidative stress, leading to drug resistance.
Purpose of the Study:
- To evaluate novel 1,2,4-triazole-3-thione derivatives for antioxidant and anticonvulsant activities.
- To assess the efficacy of these compounds in a preclinical model of pharmacoresistant epilepsy.
- To investigate potential mechanisms of action and off-target effects.
Main Methods:
- Anticonvulsant activity was tested using the 6 Hz psychomotor seizure test in mice.
- Antioxidant activity was assessed using DPPH, CUPRAC assays, and flow cytometry for reactive oxygen species (ROS) scavenging.
- Enzymatic studies were conducted on human carbonic anhydrases (CAs), acetylcholinesterase (AChE), and butyrylcholinesterase (BChE).
Main Results:
- The 1,2,4-triazole-3-thione derivatives demonstrated 2-3 times greater anticonvulsant potency than valproic acid in the 6 Hz model.
- Compounds exhibited significant antioxidant and ROS scavenging activity.
- Enzymatic studies suggest minimal impact on cognitive processes and cholinergic pathways.
Conclusions:
- The investigated 1,2,4-triazole-3-thione derivatives represent a promising class of compounds for treating pharmacoresistant epilepsy.
- Their potent antioxidant and anticonvulsant properties, coupled with a favorable preliminary safety profile, warrant further investigation.
Related Concept Videos
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:14Antiepileptic Drugs: Glutamate Antagonists
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...